These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1828055)

  • 1. Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.
    Leader KA; Kumpel BM; Hadley AG; Bradley BA
    Immunology; 1991 Apr; 72(4):481-5. PubMed ID: 1828055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
    Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
    Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
    Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
    Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the functional topography of Fc gamma with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptor on human K cells.
    Sármay G; Jefferis R; Klein E; Benczur M; Gergely J
    Eur J Immunol; 1985 Oct; 15(10):1037-42. PubMed ID: 2414110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of intracellular Ca2+ mobilization and cytotoxicity by hybrid mouse monoclonal antibodies. Fc gamma RII regulation of Fc gamma RI-triggered functions or signaling?
    Koolwijk P; Van de Winkel JG; Pfefferkorn LC; Jacobs CW; Otten I; Spierenburg GT; Bast BJ
    J Immunol; 1991 Jul; 147(2):595-602. PubMed ID: 1830069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors.
    Walker MR; Lund J; Thompson KM; Jefferis R
    Biochem J; 1989 Apr; 259(2):347-53. PubMed ID: 2524188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism.
    Van Schie RC; Verstraten RG; Van de Winkel JG; Tax WJ; de Mulder PH
    J Immunol; 1992 Jan; 148(1):169-76. PubMed ID: 1530794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
    Griffiths HL; Kumpel BM; Elson CJ; Hadley AG
    Immunology; 1994 Nov; 83(3):370-7. PubMed ID: 7835961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphic Fc receptor for mouse IgG2b on human B cells and monocytes.
    Holtrop S; Rijke-Schilder GP; Koene RA; Tax WJ
    Immunology; 1991 Dec; 74(4):613-20. PubMed ID: 1838352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
    Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
    Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
    Littaua R; Kurane I; Ennis FA
    J Immunol; 1990 Apr; 144(8):3183-6. PubMed ID: 2139079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.
    Guyre PM; Graziano RF; Vance BA; Morganelli PM; Fanger MW
    J Immunol; 1989 Sep; 143(5):1650-5. PubMed ID: 2474608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RII.
    Gosselin EJ; Brown MF; Anderson CL; Zipf TF; Guyre PM
    J Immunol; 1990 Mar; 144(5):1817-22. PubMed ID: 1689755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
    J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.
    Ierino FL; Hulett MD; McKenzie IF; Hogarth PM
    J Immunol; 1993 Mar; 150(5):1794-803. PubMed ID: 7679695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional properties of Fc gamma RI, II and III on myeloid cells: a comparative study of killing of erythrocytes and tumor cells mediated through the different Fc receptors.
    Shen L; Graziano RF; Fanger MW
    Mol Immunol; 1989 Oct; 26(10):959-69. PubMed ID: 2531842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment.
    Kumpel BM; Wang Y; Griffiths HL; Hadley AG; Rook GA
    Hum Antibodies Hybridomas; 1995; 6(3):82-8. PubMed ID: 8597627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation-related changes in the expression of Fc gamma RII and Fc gamma RIII on mouse mast cells derived in vitro and in vivo.
    Katz HR; Arm JP; Benson AC; Austen KF
    J Immunol; 1990 Nov; 145(10):3412-7. PubMed ID: 1700009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis.
    Kumpel BM; Leader KA; Merry AH; Hadley AG; Poole GD; Blancher A; Goossens D; Hughes-Jones NC; Bradley BA
    Eur J Immunol; 1989 Dec; 19(12):2283-8. PubMed ID: 2481589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.